home / stock / orinf / orinf short
Short Information | Orion Corp New B Shs (OTCMKTS:ORINF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 6,090 |
Total Actual Volume | 6,092 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 13 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 305 |
Average Short Percentage | 62.50% |
Is there a ORINF Short Squeeze or Breakout about to happen?
See the ORINF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-28-2024 | $0 | $47.16 | $0 | $0 | 5 | 5 | 100% |
09-28-2023 | $38.381 | $38.381 | $38.381 | $38.381 | 1,509 | 1,509 | 100% |
07-21-2023 | $0 | $46 | $0 | $0 | 10 | 10 | 100% |
07-13-2023 | $0 | $46 | $0 | $0 | 1,346 | 1,346 | 100% |
05-15-2023 | $46 | $46 | $46 | $46 | 100 | 100 | 100% |
09-09-2020 | $45.85 | $45.85 | $45.85 | $45.85 | 210 | 210 | 100% |
05-20-2019 | $N/A | $37.30 | $N/A | $N/A | 4 | 2 | 50% |
03-27-2019 | $37.30 | $37.30 | $37.30 | $37.30 | 100 | 100 | 100% |
02-12-2019 | $N/A | $36.10 | $N/A | $N/A | 27 | 27 | 100% |
01-10-2019 | $37.70 | $37.70 | $37.70 | $37.70 | 520 | 520 | 100% |
10-30-2018 | $35.3702 | $35.3702 | $35.3702 | $35.3702 | 854 | 854 | 100% |
04-02-2018 | $N/A | $35.8801 | $N/A | $N/A | 26 | 26 | 100% |
03-29-2018 | $N/A | $35.8801 | $N/A | $N/A | 1,381 | 1,381 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Orion Corp New B Shs Company Name:
ORINF Stock Symbol:
OTCMKTS Market:
ORION CORPORATION PRESS RELEASE 26 JANUARY 2024 at 09.00 EET Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024 Orion presented yesterday at the 2024 ASCO GU Cancers Symposium a poster with additional data from the ongoing Phase II CYPIDES trial evaluating the safety...
ORION CORPORATION PRESS RELEASE 8 JANUARY 2024 at 09.00 EET Orion and Glykos announce research collaboration and licensing agreement to develop next-generation ADCs Orion Corporation and Glykos Finland Oy announced today that they have entered into a research collaborat...
ORION CORPORATION PRESS RELEASE 05 JANUARY 2023 at 13:45 EET Orion and MSD Announce Initiation of Two Phase 3 Trials Evaluating ODM-208/MK5684 in Certain Patients with Metastatic Castration-Resistant Prostate Cancer OMAHA1 and OMAHA2a are the first Phase 3 trials to be initiated for...